DFDA

Atorvastatin

Treatment for Chronic Kidney Disease Due To Diabetes Mellitus Type 1

Typical Dosage: 10-80mg daily

Effectiveness
80%
Safety Score
65%
Clinical Trials
500
Participants
500K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-80mg daily
Time to Effect
Weeks for lipid lowering, months to years for CV event reduction
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
30(Treat 30 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
100(Treat 100 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$50
Side Effect Mgmt:$20
Total Annual:$120
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$141
Atorvastatin Outcomes

for Chronic Kidney Disease Due To Diabetes Mellitus Type 1

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Common Side Effects
Myalgia/Muscle pain
+7%
GI upset
+4%
Liver enzyme elevation
+1%

Sources:

nih.gov
amegroups.org
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov